Through its unique and integrated technology platform, Tengion is researching and developing product candidates with the potential to transform the treatment of organ and tissue impairment, failure and loss. The Company's plan is to develop, manufacture, and market a suite of autologous regenerative products.
A clinical trial of Tengion’s Neo-Urinary Conduit™ is ongoing in patients with bladder cancer who require a total cystectomy. For more information on the study of the Neo-Urinary Conduit in patients with bladder cancer, click here.
If you have medical questions, you should discuss them with your own doctor. We do not provide medical guidance beyond that of our Clinical trial center experts and medical monitor. More information on clinical trials is available at www.clinicaltrials.gov. Additional information can be obtained from Tengion at the 'Contact Us' page.